| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | VRNO Verano Holdings Corp. | Archos George Peter | Chief Executive Officer | Sell | 4,660 | $2.59 | $12,069.40 | -0.7% | - | - | |
| Aug 23, 2023 | DVAX Dynavax Technologies Corp | Janssen Robert71 | SVP And CMO | Sell | 34,857 | $15.01 | $523,203.57 | -41.1% | -9.6% | -24.7% | |
| Aug 23, 2023 | LLY Eli Lilly & Co | Lilly Endowment Inc | 10% Owner | Sell | 1,307 | $555.69 | $726,284.48 | - | +7.1% | +72.4% | |
| Aug 23, 2023 | ANIP Ani Pharmaceuticals Inc | Marken James G.47 | SVP Ops &Prod Dev | Sell | 3,932 | $63.00 | $247,716.00 | -2.9% | -18.8% | -5.1% | |
| Aug 23, 2023 | ANIP Ani Pharmaceuticals Inc | Gutwerg Ori47 | SVP, Generics | Sell | 15,561 | $62.39 | $970,850.79 | -11.2% | -18.8% | -5.1% | |
| Aug 22, 2023 | ZTS Zoetis Inc. | Peck Kristin C66 | Chief Executive Officer | Sell | 13,000 | $179.97 | $2,339,563.54 | -9.9% | -3.2% | +0.6% | |
| Aug 21, 2023 | LLY Eli Lilly & Co | Zakrowski Donald A | SVP, Finance, &CAO | Sell | 600 | $546.51 | $327,906.00 | -10.0% | +8.6% | +72.7% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Gano Kyle54 | Chief Business Development Off | Sell | 2,132 | $107.41 | $228,992.79 | -1.6% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Abernethy Matt57 | Chief Financial Officer | Sell | 2,132 | $107.39 | $228,958.46 | -7.3% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,600 | $107.41 | $171,862.08 | -20.5% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Roberts Eiry49 | Chief Medical Officer | Sell | 3,198 | $107.38 | $343,387.81 | -9.8% | +1.0% | +38.1% | |
| Aug 21, 2023 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 6,698 | $6.92 | $46,319.35 | -5.1% | +10.6% | +136.1% | |
| Aug 21, 2023 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 408 | $66.10 | $26,968.80 | -0.5% | +2.7% | +46.2% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Cooke Julie59 | Chief Human Resources Officer | Sell | 2,132 | $107.41 | $228,990.66 | -10.5% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Lippoldt Darin60 | Chief Legal Officer | Sell | 2,132 | $107.39 | $228,951.22 | -4.3% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Delaet Ingrid67 | Chief Regulatory Officer | Sell | 1,404 | $107.42 | $150,820.35 | -23.2% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Benevich Eric62 | Chief Commercial Officer | Sell | 1,600 | $107.40 | $171,836.00 | -4.2% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Onyia Jude54 | Chief Scientific Officer | Sell | 3,198 | $107.37 | $343,367.98 | -24.9% | +1.0% | +38.1% | |
| Aug 21, 2023 | NBIX Neurocrine Biosciences Inc | Gorman Kevin Charles55 | Chief Executive Officer | Sell | 9,328 | $107.40 | $1,001,816.01 | -1.8% | +1.0% | +38.1% | |
| Aug 18, 2023 | LNTH Lantheus Holdings, Inc. | Blanchfield Paul54 | President | Sell | 1,500 | $65.19 | $97,785.00 | -1.6% | +2.8% | +43.2% | |
| Aug 18, 2023 | CBSTF Cannabist Co Holdings Inc. | Hart David James | President &COO | Sell | 250,000 | $0.43 | $106,250.00 | -17.8% | - | - | |
| Aug 18, 2023 | ESPR Esperion Therapeutics, Inc. | Warren Eric60 | Chief Commercial Officer | Sell | 243 | $1.41 | $343.60 | -0.4% | -23.4% | +35.2% | |
| Aug 18, 2023 | AMPH Amphastar Pharmaceuticals, Inc. | Prins Richard K61 | Director | Sell | 2,000 | $52.50 | $105,005.60 | -4.7% | +6.2% | -15.0% | |
| Aug 17, 2023 | UTHR United Therapeutics Corp | Mahon Paul A47 | EVP &General Counsel | Sell | 6,000 | $229.54 | $1,377,265.02 | -3.7% | +0.5% | +40.7% | |
| Aug 17, 2023 | TLLTF Tilt Holdings Inc. | Hoch Brad | Interim CFO | Buy | 100,000 | $0.28 | $28,340.00 | +240.9% | - | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.